| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | Chief Scientific Officer | Mar 11, 2024 | Sale | $0.88 | 14,235 | 12,552 | 234,301 | Mar 11, 2024, 05:20 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | Chief Scientific Officer | Feb 12, 2024 | Sale | $1.01 | 787 | 793 | 248,536 | Feb 12, 2024, 05:23 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | Chief Scientific Officer | Nov 01, 2023 | Sale | $0.73 | 67,695 | 49,417 | 249,323 | Nov 03, 2023, 04:39 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | Chief Scientific Officer | Mar 10, 2023 | Sale | $0.84 | 16,806 | 14,117 | 86,373 | Mar 13, 2023, 04:48 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Taveras Arthur | Chief Scientific Officer | Feb 13, 2023 | Sale | $0.93 | 928 | 863 | 103,179 | Feb 15, 2023, 05:13 PM |
Menu